These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34149624)

  • 1. Blood Sampling From Rat Ileal Mesenteric Vein Revealed a Major Role of Dietary Protein in Meal-Induced GLP-1 Response.
    Hira T; Sekishita M; Hara H
    Front Endocrinol (Lausanne); 2021; 12():689685. PubMed ID: 34149624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial glucagon-like peptide-1 secretion is increased during the progression of glucose intolerance and obesity in high-fat/high-sucrose diet-fed rats.
    Nakajima S; Hira T; Hara H
    Br J Nutr; 2015 May; 113(9):1477-88. PubMed ID: 25827219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating concentrations of glucagon-like peptide 1, glucose-dependent insulinotropic peptide, peptide YY, and insulin in client-owned lean, overweight, and diabetic cats.
    McMillan CJ; Zapata RC; Chelikani PK; Snead EC; Cosford K
    Domest Anim Endocrinol; 2016 Jan; 54():85-94. PubMed ID: 26609567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
    Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
    Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose.
    Powell DR; Smith M; Greer J; Harris A; Zhao S; DaCosta C; Mseeh F; Shadoan MK; Sands A; Zambrowicz B; Ding ZM
    J Pharmacol Exp Ther; 2013 May; 345(2):250-9. PubMed ID: 23487174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves.
    Mayer F; Gunawan AL; Tso P; Aponte GW
    Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G23-G35. PubMed ID: 32421358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing dietary fat from a meal increases the bioavailability of exogenous carbohydrate without altering plasma glucose concentration.
    Knuth ND; Shrivastava CR; Horowitz JF
    J Appl Physiol (1985); 2009 Jan; 106(1):122-9. PubMed ID: 19008494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.
    Ruetten H; Gebauer M; Raymond RH; Calle RA; Cobelli C; Ghosh A; Robertson RP; Shankar SS; Staten MA; Stefanovski D; Vella A; Wright K; Fryburg DA;
    Metab Syndr Relat Disord; 2018 Oct; 16(8):406-415. PubMed ID: 30117761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between Postprandial Gut Hormones and Markers of Bone Remodeling.
    Jensen NW; Clemmensen KKB; Jensen MM; Pedersen H; Færch K; Diaz LJ; Quist JS; Størling J
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
    Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
    Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a dietary fat-dependent manner.
    Hata T; Mera Y; Ishii Y; Tadaki H; Tomimoto D; Kuroki Y; Kawai T; Ohta T; Kakutani M
    J Pharmacol Exp Ther; 2011 Mar; 336(3):850-6. PubMed ID: 21139060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.
    Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    J Clin Endocrinol Metab; 2011 Feb; 96(2):447-53. PubMed ID: 21047927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents.
    Zhou J; Martin RJ; Tulley RT; Raggio AM; McCutcheon KL; Shen L; Danna SC; Tripathy S; Hegsted M; Keenan MJ
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1160-6. PubMed ID: 18796545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of exogenous hyperglucagonemia on postprandial concentrations of gastric inhibitory polypeptide and glucagon-like peptide-1 in humans.
    Meier JJ; Ritter PR; Jacob A; Menge BA; Deacon CF; Schmidt WE; Nauck MA; Holst JJ
    J Clin Endocrinol Metab; 2010 Aug; 95(8):4061-5. PubMed ID: 20501678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus.
    Aaboe K; Knop FK; Vilsbøll T; Deacon CF; Holst JJ; Madsbad S; Krarup T
    Diabetes Obes Metab; 2010 Apr; 12(4):323-33. PubMed ID: 20380653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasting and postprandial concentrations of GLP-1 in intestinal lymph and portal plasma: evidence for selective release of GLP-1 in the lymph system.
    D'Alessio D; Lu W; Sun W; Zheng S; Yang Q; Seeley R; Woods SC; Tso P
    Am J Physiol Regul Integr Comp Physiol; 2007 Dec; 293(6):R2163-9. PubMed ID: 17898126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction.
    Evans S; Pamuklar Z; Rosko J; Mahaney P; Jiang N; Park C; Torquati A
    Surg Endosc; 2012 Apr; 26(4):1086-94. PubMed ID: 22044971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males.
    Heruc GA; Horowitz M; Deacon CF; Feinle-Bisset C; Rayner CK; Luscombe-Marsh N; Little TJ
    Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E830-7. PubMed ID: 25231186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ileal Transposition Decreases Plasma Lipopolysaccharide Levels in Association with Increased L Cell Secretion in Non-obese Non-diabetic Rats.
    Oh TJ; Lee HJ; Cho YM
    Obes Surg; 2016 Jun; 26(6):1287-95. PubMed ID: 26334758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous feeding of a combined high-fat and high-sucrose diet, rather than an individual high-fat or high-sucrose diet, rapidly enhances the glucagon-like peptide-1 secretory response to meal ingestion in diet-induced obese rats.
    Pinyo J; Hira T; Hara H
    Nutrition; 2019 Jun; 62():122-130. PubMed ID: 30878816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.